Sign up to access historical data
Similar companies
| Company | Est. Transaction Value | |
|---|---|---|
 |
PfizerPFE |
-$500 |
 |
AstrazenecaAZN |
$16,000 |
 |
Johnson & JohnsonJNJ |
-$220,000 |
 |
ModernaMRNA |
$24,000 |
 |
Eli Lilly and CompanyLLY |
-$230,000 |
Trades by US Politicians
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Julie Johnson | Aug 14, 2025 | Sell | $1K - $15K |
| Marjorie Taylor Greene | Aug 4, 2025 | Buy | $1K - $15K |
| Lisa McClain | Jul 22, 2025 | Buy | $1K - $15K |
| Ritchie Torres | Jul 11, 2025 | Sell | $1K - $15K |
| Lisa McClain | Jun 17, 2025 | Buy | $1K - $15K |
| Josh Gottheimer | May 22, 2025 | Buy | $1K - $15K |
| Rob Bresnahan | May 15, 2025 | Buy | $1K - $15K |
| Marjorie Taylor Greene | May 5, 2025 | Buy | $1K - $15K |
| Jefferson Shreve | Apr 17, 2025 | Sell | $50K - $100K |
| Jared Moskowitz | Apr 7, 2025 | Buy | $1K - $15K |
| Josh Gottheimer | Apr 3, 2025 | Buy | $1K - $15K |
| Dwight Evans | Apr 3, 2025 | Sell | $1K - $15K |
| Josh Gottheimer | Apr 1, 2025 | Buy | $1K - $15K |
| Marjorie Taylor Greene | Mar 17, 2025 | Buy | $1K - $15K |
| Rob Bresnahan | Feb 25, 2025 | Buy | $1K - $15K |
| Jefferson Shreve | Feb 24, 2025 | Buy | $50K - $100K |
| Jared Moskowitz | Jan 15, 2025 | Buy | $1K - $15K |
| Virginia Foxx | Dec 6, 2024 | Buy | $1K - $15K |
| Marjorie Taylor Greene | Nov 20, 2024 | Buy | $1K - $15K |
| Marjorie Taylor Mrs Greene | Nov 20, 2024 | Buy | $1K - $15K |
| Ro Khanna | Oct 14, 2024 | Buy | $1K - $15K |
| Ritchie Torres | Sep 26, 2024 | Buy | $1K - $15K |
| Kathy Manning | Jul 2, 2024 | Buy | $1K - $15K |
| Rohit Khanna Democrat | May 29, 2024 | Sell | $1K - $15K |
| Rohit Khanna Democrat | Apr 23, 2024 | Sell | $1K - $15K |
| Michael Burgess Republican | Apr 10, 2024 | Sell | $1K - $15K |
| William Keating Democrat | Mar 27, 2024 | Buy | $15K - $50K |
| Rohit Khanna Democrat | Feb 13, 2024 | Buy | $1K - $15K |
| Kathy Manning Democrat | Jan 23, 2024 | Buy | $1K - $15K |
| Thomas Tuberville Republican | Jan 19, 2024 | Sell | $1K - $15K |
| Rohit Khanna Democrat | Jan 10, 2024 | Buy | $15K - $50K |
| Rohit Khanna Democrat | Jan 10, 2024 | Buy | $1K - $15K |
| Michael Burgess Republican | Dec 8, 2023 | Sell | $1K - $15K |
| Thomas Tuberville Republican | Nov 20, 2023 | Sell | $1K - $15K |
| John James | Nov 10, 2023 | Buy | $1K - $15K |
| Joshua Gottheimer Democrat | Nov 8, 2023 | Sell | $1K - $15K |
Who is the latest politician to buy or sell AbbVie shares?
Julie Johnson sold AbbVie shares most recently on August 14, 2025.
Which politician has bought the most ABBV stock in the last two years?
Jefferson Shreve has bought the most ABBV stock in the last 2 years, with an estimated value of $75,000.
Which politician has sold the most ABBV stock over the last two years?
Jefferson Shreve has sold the most ABBV stock in the last 2 years, with an estimated value of $75,000.
What is the total value of politicians trading ABBV stock in the last 2 years?
According to our estimates, the net value of trades by US politicians for AbbVie in the last 2 years is positive, amounting to $130,000. This indicates that US politicians have reasons to believe that the stock is going to go up.
How do insider transactions over the last 2 years reflect on AbbVie's market confidence?
Over the last 2 years, insider transactions for AbbVie have predominantly involved purchasing shares, indicating a strong confidence among insiders in the company's future prospects. This trend of more purchases than sales could be a positive signal to potential investors about the politicians view on the company's future and growth potential.
Why should individual investors pay attention to the stock transactions of US politicians?
Monitoring US politicians' stock trades is valuable because they may have inside information about upcoming policies that could affect stock values, providing investors with valuable clues for making informed decisions.
